How to Help Your Patients Find Erythromycin Ethylsuccinate In Stock: A Provider's Guide

If you've prescribed Erythromycin Ethylsuccinate recently, there's a good chance you've received a callback: the patient can't fill it, the pharmacy doesn't have it in stock, and they're asking what to do. This guide gives you the tools, talking points, and workflow adjustments to handle this situation efficiently — and ideally prevent the callback in the first place.

Why Fill Failures Happen with E.E.S.

Erythromycin Ethylsuccinate is not in an FDA shortage, but it's also not a high-volume medication at most chain pharmacies. The result: many retail chains simply don't keep it routinely stocked. The most common fill failure scenarios are:

Patient goes to their regular CVS, Walgreens, or Rite Aid — pharmacy doesn't have it and says it will take 1–3 days to order

Prescription written for the 200mg/5mL suspension (the pediatric-targeted form) — harder to find than the 400mg/5mL or tablets

Patient is in a smaller or rural community with limited pharmacy options

Prescription written during a pertussis outbreak, when demand spikes unexpectedly

Prescribing Strategies That Prevent Fill Failures

1. Prescribe Generically and Allow Substitution

Always prescribe "erythromycin ethylsuccinate" generically rather than by brand name (E.E.S. or EryPed). This gives pharmacies maximum flexibility to source from any available manufacturer. If you're writing for a brand and that brand isn't stocked, the pharmacist may not automatically substitute — especially in systems with brand-required flags.

2. Note Formulation Flexibility When Clinically Appropriate

If the patient can tolerate either the suspension or the tablet (older children, adolescents, adults), add a note to the prescription: "May dispense as tablet or suspension — patient and caregiver instructed." This dramatically expands the pool of pharmacies that can fill immediately.

38,766+ patients found their medications in stock

38K+

Find Erythromycin Ethylsuccinate In Stock Today →

3. Verify Pharmacy Stock Before Sending the Prescription

Using medfinder for providers, your staff can check which pharmacies in the patient's area have Erythromycin Ethylsuccinate in stock before sending the e-prescription. This takes the guesswork out of it and prevents the patient from being sent to a pharmacy that can't fill their prescription.

4. Direct Patients to Independent Pharmacies

Small, independent community pharmacies are significantly more likely to stock E.E.S. or be willing to special-order it quickly than large retail chains. Consider maintaining a short list of independent pharmacies near your practice that you can recommend for less-commonly stocked medications.

Skip the calls, skip the stress.

Find Erythromycin Ethylsuccinate In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Patient Communication: What to Tell Them Before They Leave

Setting expectations at the point of prescribing can dramatically reduce callback volume. A brief heads-up to the patient at checkout takes 30 seconds but prevents a frustrating phone tag cycle. Consider language like:

"This is an older antibiotic that not all pharmacies keep on their shelves. If your regular pharmacy doesn't have it, try an independent pharmacy or use medfinder.com — they'll contact pharmacies near you to find which one has it."

Handling the Callback: A Quick Workflow

When a patient calls back because they can't fill their E.E.S. prescription, your MA or front desk can follow this simple triage:

Confirm the exact formulation and strength prescribed (suspension vs. tablet, 200 vs. 400mg)

Ask if patient has tried independent pharmacies or warehouse pharmacies (Costco, Sam's Club)

Direct patient to medfinder.com to identify pharmacies with confirmed stock near them

If patient cannot fill within 24–48 hours AND the clinical situation is urgent (e.g., confirmed pertussis, active chlamydia, acute strep), escalate to prescriber for alternative antibiotic consideration

Special Considerations: Neonates and Infants

For very young patients (neonates or infants under 2 months), the prescribing situation is more nuanced. Erythromycin in neonates is associated with risk of infantile hypertrophic pyloric stenosis (IHPS) — reported primarily when used for pertussis prophylaxis. Current CDC guidelines recommend azithromycin as first-line for pertussis in neonates and infants precisely because of this risk. For indications like neonatal chlamydial conjunctivitis, E.E.S. suspension remains used but the prescriber should be prepared to counsel parents about the IHPS association.

medfinder for Providers: The Easiest Solution

The most efficient way to solve E.E.S. fill problems proactively is to use medfinder for providers. Your practice can verify real-time pharmacy availability for any medication before writing the prescription — including Erythromycin Ethylsuccinate. This saves staff time, eliminates unnecessary callbacks, and ensures your patients get their medications when they need them.

For a broader supply situation overview, see our clinical briefing: Erythromycin Ethylsuccinate shortage — what providers need to know in 2026.